HIV/HTLV-I coinfection and clinical grade at diagnosis. 1995

M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
INSERM U169, Recherches en Epidémiologie, Villejuif, France.

A total of 963 HIV-infected patients have been identified or followed up in Martinique since 1985. Medical files were used to retrieve information about age, sex, circumstances of diagnosis, HTLV-I status, and HIV clinical grade at first examination according to CDC criteria from 1987. Complete information was available for 774 patients. At the first clinical examination, the clinical grade of 65 coinfected patients was more severe than that of the monoinfected patients (GIV versus GII, OR = 2.60, p < 0.01), but after adjustment for age and sex, this odds ratio was reduced 1.57. Although this study cannot invalidate the hypothesis of a faster progression toward AIDS of coinfected than of monoinfected patients, it shows that one or several other mechanisms contribute to the different grades of severity at the first clinical examination observed between these two categories of patients. We believe that HTLV-I infection acquired during adulthood is a marker of high-risk behavior and that it might be associated with early or multiple HIV infections.

UI MeSH Term Description Entries
D008297 Male Males
D008395 Martinique An island in the Lesser Antilles, one of the Windward Islands. Its capital is Fort-de-France. It was discovered by Columbus in 1502 and from its settlement in 1635 by the French it passed into and out of Dutch and British hands. It was made a French overseas department in 1946. One account of the name tells of native women on the shore calling "Madinina" as Columbus approached the island. The meaning was never discovered but was entered on early charts as Martinique, influenced by the name of St. Martin. (From Webster's New Geographical Dictionary, 1988, p734 & Room, Brewer's Dictionary of Names, 1992, p339)
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015367 Human T-lymphotropic virus 2 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1. HTLV-2,HTLV-II,Human T-Cell Leukemia Virus II,Human T-Lymphotropic Virus II,Leukemia Virus II, Human T-Cell,T-Cell Leukemia Virus II, Human,Human T Cell Leukemia Virus II,Human T Lymphotropic Virus II,Leukemia Virus II, Human T Cell,T Cell Leukemia Virus II, Human,Human T lymphotropic virus 2
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1

Related Publications

M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
October 1997, Neurology,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
April 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
January 1992, Journal of acquired immune deficiency syndromes,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
January 1991, Journal of acquired immune deficiency syndromes,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
August 1998, AIDS patient care and STDs,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
October 1994, Journal of medical virology,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
March 2020, Pathogens (Basel, Switzerland),
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
March 2006, Arquivos de neuro-psiquiatria,
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
December 1992, Presse medicale (Paris, France : 1983),
M Chavance, and C Neisson-Vernant, and D Quist, and N Monplaisir, and B Armengaud, and R Chout
March 2000, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!